chr2-31529411-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_000348.4(SRD5A2):c.594C>T(p.Ile198=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00337 in 1,613,936 control chromosomes in the GnomAD database, including 22 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0027 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0034 ( 22 hom. )
Consequence
SRD5A2
NM_000348.4 synonymous
NM_000348.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.463
Genes affected
SRD5A2 (HGNC:11285): (steroid 5 alpha-reductase 2) This gene encodes a microsomal protein expressed at high levels in androgen-sensitive tissues such as the prostate. The encoded protein is active at acidic pH and is sensitive to the 4-azasteroid inhibitor finasteride. Deficiencies in this gene can result in male pseudohermaphroditism, specifically pseudovaginal perineoscrotal hypospadias (PPSH). [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 2-31529411-G-A is Benign according to our data. Variant chr2-31529411-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 459639.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-31529411-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.463 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 22 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SRD5A2 | NM_000348.4 | c.594C>T | p.Ile198= | synonymous_variant | 4/5 | ENST00000622030.2 | |
SRD5A2 | XM_011533069.3 | c.372C>T | p.Ile124= | synonymous_variant | 4/5 | ||
SRD5A2 | XM_011533072.3 | c.339C>T | p.Ile113= | synonymous_variant | 6/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SRD5A2 | ENST00000622030.2 | c.594C>T | p.Ile198= | synonymous_variant | 4/5 | 1 | NM_000348.4 | P1 | |
ENST00000435713.1 | n.255+1711G>A | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.00271 AC: 413AN: 152230Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
413
AN:
152230
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00283 AC: 704AN: 248836Hom.: 4 AF XY: 0.00279 AC XY: 377AN XY: 135000
GnomAD3 exomes
AF:
AC:
704
AN:
248836
Hom.:
AF XY:
AC XY:
377
AN XY:
135000
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00344 AC: 5027AN: 1461590Hom.: 22 Cov.: 31 AF XY: 0.00333 AC XY: 2418AN XY: 727066
GnomAD4 exome
AF:
AC:
5027
AN:
1461590
Hom.:
Cov.:
31
AF XY:
AC XY:
2418
AN XY:
727066
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00271 AC: 413AN: 152346Hom.: 0 Cov.: 32 AF XY: 0.00270 AC XY: 201AN XY: 74496
GnomAD4 genome
AF:
AC:
413
AN:
152346
Hom.:
Cov.:
32
AF XY:
AC XY:
201
AN XY:
74496
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2022 | SRD5A2: BP4, BP7 - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 25, 2015 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Dec 07, 2017 | - - |
3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at